Hydrogen Production: Macquarie Kicks Off $770M Sale of Korea’s Approtium

The article describes Macquarie Asset Management's sale of Approtium Co., Ltd., providing details on the company's growth, South Korean hydrogen policy, infrastructure, market implications, and strategic value. Most financial details, such as the estimated sale value, revenue growth, corporate history, infrastructure assets, and policy context, align with recent business and industry reporting from credible news outlets and company disclosures. However, there are multiple specific quantitative claims and forward-looking statements about revenue, deal timing, strategic bidders, and technical trials (e.g., 2026 CCS trial) that are not directly corroborated by easily accessible, independent, up-to-date public records or major news wires within the last two weeks. The article does not provide source attribution for its detailed figures or quotes, and some speculative language about market impact and investor sentiment is presented as fact, warranting qualification. The transaction is recent but not verifiable as occurring within the last 2 weeks, and some claims may rest on internal company data or undisclosed reports.